Mikko Sairanen
Mikko Sairanen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Aki Koivu
Department of Otolaryngology‐Head & Neck Surgery Massachusetts Eye & Ear Boston Massachusetts USA
3 shared publications - Teemu Korpimäki
PerkinElmer, Wallac Oy, Mustionkatu 6, 20750 Turku, Finland
2 shared publications - Antti Airola
University of Turku
1 shared publication - Daljit Singh Sahota
Department of Obstetrics and Gynaecology The Chinese University of Hong Kong Hong Kong SAR China
1 shared publication - Elin Friberg
Pediatric Cardiology, Children’s Heart Centre, Skåne University Hospital, 221 85 Lund, Sweden
1 shared publication - Heikki Kouru
PerkinElmer, Mustionkatu 6, 20750 Turku, Finland
1 shared publication
Latest Publications
- Open Access
- 12 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (8) , 3445
Exploring Biomarkers in Congenital Heart Disease: A Case–Control Study of ST2 in Children with Atrial Septal Defects
Soluble growth stimulation protein form of interleukin-1 receptor-like 1 (ST2) may signal myocardial stress, and elevated ST2 blood levels are associated with adverse outcomes in adult heart disease. Data on ST2 in children with congenital heart disease (CHD) is limited. This study explored ST2 in newborns and older children with atrial septal defect (ASD), as this represents a common CHD type that remains clinically challenging to recognize in childhood with slowly evolving symptoms. A case–control study was carried out in newborn ASD cases versus controls measuring ST2 on dried blood spot samples and additionally in pediatric ASD cases versus controls on venous blood together with cardiac magnetic resonance before and after treatment. ST2 was higher in newborns with ASD (n = 19) compared to controls (n = 93); (p < 0.01). Receiver operating characteristics to diagnose newborn ASD by ST2 showed an area under the curve of 0.848. Levels of ST2 decreased in pediatric ASD (n = 16) after treatment (p = 0.014). Lower left ventricular ejection fraction correlated with higher ST2 levels before (r = −0.348) and after treatment (r = −0.497). Elevated ST2 in newborns may aid early ASD diagnosis. Levels of ST2 in pediatric ASD decrease after treatment, and higher levels are associated with lower left ventricular ejection fraction, warranting further study.
- 12 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (8) , 3445
Open AccessExploring Biomarkers in Congenital Heart Disease: A Case–Control Study of ST2 in Children with Atrial Septal Defects
Soluble growth stimulation protein form of interleukin-1 receptor-like 1 (ST2) may signal myocardial stress, and elevated ST2 blood levels are associated with adverse outcomes in adult heart disease. Data on ST2 in children with congenital heart disease (CHD) is limited. This study explored ST2 in newborns and older children with atrial septal defect (ASD), as this represents a common CHD type that remains clinically challenging to recognize in childhood with slowly evolving symptoms. A case–control study was carried out in newborn ASD cases versus controls measuring ST2 on dried blood spot samples and additionally in pediatric ASD cases versus controls on venous blood together with cardiac magnetic resonance before and after treatment. ST2 was higher in newborns with ASD (n = 19) compared to controls (n = 93); (p < 0.01). Receiver operating characteristics to diagnose newborn ASD by ST2 showed an area under the curve of 0.848. Levels of ST2 decreased in pediatric ASD (n = 16) after treatment (p = 0.014). Lower left ventricular ejection fraction correlated with higher ST2 levels before (r = −0.348) and after treatment (r = −0.497). Elevated ST2 in newborns may aid early ASD diagnosis. Levels of ST2 in pediatric ASD decrease after treatment, and higher levels are associated with lower left ventricular ejection fraction, warranting further study.
- Open Access
- 1 November 2021
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 138, 104886
Adaptive risk prediction system with incremental and transfer learning
- 1 November 2021
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 138, 104886
Open AccessAdaptive risk prediction system with incremental and transfer learning
- Open Access
- 25 March 2020
- Published by Springer Nature in Health Information Science and Systems
- Vol. 8 (1) , 1-12
Predicting risk of stillbirth and preterm pregnancies with machine learning
Modelling the risk of abnormal pregnancy-related outcomes such as stillbirth and preterm birth have been proposed in the past. Commonly they utilize maternal demographic and medical history information as predictors, and they are based on conventional statistical modelling techniques. In this study, we utilize state-of-the-art machine learning methods in the task of predicting early stillbirth, late stillbirth and preterm birth pregnancies. The aim of this experimentation is to discover novel risk models that could be utilized in a clinical setting. A CDC data set of almost sixteen million observations was used conduct feature selection, parameter optimization and verification of proposed models. An additional NYC data set was used for external validation. Algorithms such as logistic regression, artificial neural network and gradient boosting decision tree were used to construct individual classifiers. Ensemble learning strategies of these classifiers were also experimented with. The best performing machine learning models achieved 0.76 AUC for early stillbirth, 0.63 for late stillbirth and 0.64 for preterm birth while using a external NYC test data. The repeatable performance of our models demonstrates robustness that is required in this context. Our proposed novel models provide a solid foundation for risk prediction and could be further improved with the addition of biochemical and/or biophysical markers.
- 25 March 2020
- Published by Springer Nature in Health Information Science and Systems
- Vol. 8 (1) , 1-12
Open AccessPredicting risk of stillbirth and preterm pregnancies with machine learning
Modelling the risk of abnormal pregnancy-related outcomes such as stillbirth and preterm birth have been proposed in the past. Commonly they utilize maternal demographic and medical history information as predictors, and they are based on conventional statistical modelling techniques. In this study, we utilize state-of-the-art machine learning methods in the task of predicting early stillbirth, late stillbirth and preterm birth pregnancies. The aim of this experimentation is to discover novel risk models that could be utilized in a clinical setting. A CDC data set of almost sixteen million observations was used conduct feature selection, parameter optimization and verification of proposed models. An additional NYC data set was used for external validation. Algorithms such as logistic regression, artificial neural network and gradient boosting decision tree were used to construct individual classifiers. Ensemble learning strategies of these classifiers were also experimented with. The best performing machine learning models achieved 0.76 AUC for early stillbirth, 0.63 for late stillbirth and 0.64 for preterm birth while using a external NYC test data. The repeatable performance of our models demonstrates robustness that is required in this context. Our proposed novel models provide a solid foundation for risk prediction and could be further improved with the addition of biochemical and/or biophysical markers.
- 1 July 2018
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 98, 1-7
Evaluation of machine learning algorithms for improved risk assessment for Down's syndrome
- 1 July 2018
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 98, 1-7
Evaluation of machine learning algorithms for improved risk assessment for Down's syndrome
- 1 October 2017
- Published by Elsevier in Metabolism
- Vol. 75, 6-15
Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia
- 1 October 2017
- Published by Elsevier in Metabolism
- Vol. 75, 6-15
Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia